STAT5B and T-cell large granular lymphocyte leukemia: As CD4+ T-LGLL is a rare disease, previous studies evaluating the clinical impact of STAT5B mutations have been limited in size, and no deep TCR profiling has been performed with modern sequencing and bioinformatic tools [23–25].